Blue Earth Diagnostics, one of the Bracco family of companies, is an industry leader in precision imaging radiopharmaceuticals to help diagnose, stage and monitor cancer for patients in areas of unmet medical need. Its products include a world-class franchise of PET diagnostic imaging agents for prostate cancer and an expanding pipeline portfolio that spans a variety of disease states, including neuro-oncology and multiple solid tumors. For more information, please visit: blueearthdiagnostics.com and prostatecancer-blueearthdx.com.